Activation of the nuclear factor E2-related factor 2 pathway by novel natural products halomadurones A-D and a synthetic analogue

Marine Drugs

Volumn 11, Issue 12, 2013, Pages 5089-5099

  Wyche, Thomas P ^a   Standiford, Miranda ^a   Hou, Yanpeng ^a   Braun, Doug ^a   Johnson, Delinda A ^a   Johnson, Jeffrey A ^a   Bugni, Tim S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Actinomadura; Ecteinascidia turbinata; Halomadurones; Nuclear factor E2 related factor antioxidant element

Indexed keywords

2 METHYL 6 (3 METHYL 1,3 HEXADIENE)GAMMA PYRONE; HALOMADURONE A; HALOMADURONE B; HALOMADURONE C; HALOMADURONE D; PYRONE DERIVATIVE; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ACTINOMADURA; ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; ASCIDIACEA; BRAIN CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; ECTEINASCIDIA TURBINATA; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE;

ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; BACTERIA; BIOLOGICAL PRODUCTS; CELLS, CULTURED; HALOGENS; MICE; NEURODEGENERATIVE DISEASES; NF-E2-RELATED FACTOR 2; PYRONES; SIGNAL TRANSDUCTION;

EID: 84892424933     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md11125089     Document Type: Article

References (32)

1. Menken, M.; Munsat, T.L.; Toole, J.F. The global burden of disease study: Implications for neurology. Arch. Neurol. 2000, 57, 418-420.
2. Hebert, L.E.; Weuve, J.; Scherr, P.A.; Evans, D.A. Alzheimer disease in the United States (2010-2050) estimated during the 2010 census. Neurology 2013, 80, 1778-1783.
3. Alzheimer's Disease International. World Alzheimer Report 2009; Prince, M., Jackson, J., Eds.; Alzheimer's Disease International: London, UK, 2009.
4. Uttara, B.; Singh, A.V.; Zamboni, P.; Mahajan, R.T. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7, 65-74.
5. De Vries, H.E.; Witte, M.; Hondius, D.; Rozemuller, A.J.M.; Drukarch, B.; Hoozemans, J.; van Horssen, J. Nrf2-induced antioxidant protection: A promising target to conteract ROS-mediated damage neurodegenerative disease? Free Radic. Biol. Med. 2008, 45, 1375-1383.
6. Calkins, M.J.; Johnson, D.A.; Townsend, J.A.; Vargas, M.R.; Dowell, J.A.; Williamson, T.P.; Kraft, A.D.; Lee, J.-M.; Li, J.; Johnson, J.A. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signal. 2009, 11, 497-508.
7. Vanugopal, R.; Jaiswal, A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene. Proc. Natl. Acad. Sci. USA 1996, 93, 14960-14965.
8. Itoh, K.; Ishii, T.; Wakabayashi, N.; Yamamoto, M. Regulatory mechanism of cellular response to oxidative stress. Free Radical Res. 1999, 31, 319-324.
9. Wild, A.C.; Moinova, H.R.; Mulcahy, R.T. Regulation of γ-glutamylcysteine synthetase subunit gene expression by the transription factor Nrf2. J. Biol. Chem. 1999, 274, 33627-33636.
10. Kraft, A.D.; Johnson, D.A.; Johnson, J.A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 2004, 24, 1101-1112.
11. Johnson, D.A.; Andrews, G.K.; Xu, W.; Johnson, J.A. Activation of the antioxidant response element in primary cortical neuronal cultures derived from transgenic reporter mice. J. Neurochem. 2002, 81, 1233-1241.
12. Balogun E.; Hoque, M.; Gong, P.; Killeen, E.; Green, C.J.; Foresti, R.; Alam, J.; Motterlini, R. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 2003, 371, 887-895.
13. Haridas, V.; Hanausek, M.; Nishimura, G.; Soehnge, H.; Gaikwad, A.; Narog, M.; Spears, E.; Zoltaszek, R.; Walaszek, Z.; Gutterman, J.U. Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. J. Clin. Invest. 2004, 113, 65-73.
14. Shibuya, A.; Onda, K.; Kawahara, H.; Uchiyama, Y.; Nakayama, H.; Omi, T.; Nagaoka, M.; Matsui, H.; Hirano, T. Sofalcone, a gastric mucosa protective agent, increases vascular endothelial growth factor via the Nrf2-heme-oxygenase- 1 dependent pathway in gastric epithelial cells. Biochem. Biophys. Res. Commun. 2010, 398, 581-584.
15. Lee, Y.M.; Jeong, G.S.; Lim, H.D.; An, R.B.; Kim, Y.C.; Kim, E.C. Isoliquiritigenin 2′-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1. Toxicol. Vitro 2010, 24, 776-782.
16. Wang, R.; Mason, D.E.; Choe, K.P.; Lewin, A.S.; Peters, E.C.; Luesch, H. In vitro and in vivo characterization of a tunable dual-reactivity probe of the Nrf2-ARE Pathway. ACS Chem. Biol. 2013, 8, 1764-1774.
17. Wang, R.; Paul, V.; Luesch, H. Seaweed extracts and unsaturated fatty acid constituents from the green alga Ulva lactuca as activators of the cytoprotective Nrf2-ARE pathway. Free Radic. Biol. Med. 2013, 57, 141-153.
18. Orjala, J.; Gerwick, W.H. Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean cyanobacterium Lyngbya majuscula. J. Nat. Prod. 1996, 59, 427-430.
19. Jiménez, J.I.; Scheuer, P.J. New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2001, 64, 200-203.
20. Nozoe, S.; Ishii, N.; Kusano, G.; Kikuchi, K.; Ohta, T. Neocarzilins A and B, novel polyenones from Streptomyces carzinostaticus. Tetrahedron Lett. 1992, 33, 7547-7550.
21. Nozoe, S.; Kikuchi, K.; Ishii, N.; Ohta, T. Synthesis of neocarzilin A: An absolute sterochemistry. Tetrahedron Lett. 1992, 33, 7551-7552.
22. Otsuka, M.; Ichinose, K.; Fujii, I.; Ebizuka, Y. Cloning, sequencing, and functional analysis of an iterative type I polyketide synthase gene cluster for biosynthesis of the antitumor chlorinated polyenone neocarzilin in "Streptomyces carzinostaticus". Antimicrob. Agents Chemother. 2004, 48, 3468-3476.
23. Hou, Y.; Braun, D.R.; Michel, C.R.; Klassen, J.L.; Adnani, N.; Wyche, T.P.; Bugni, T.S. Microbial strain prioritization using metabolomics tools for the discovery of the natural products. Anal. Chem. 2012, 84, 4277-4283.
24. Zeng, J.; Zhan, J. A novel fungal flavin-dependent halogenase for natural product biosynthesis. ChemBioChem 2010, 11, 2119-2123.
25. Vaillancourt, F.H.; Vosburg, D.A.; Walsh, C.T. Dichlorination and bromination of a Threonyl-S-carrier protein by the non-heme FeII halogenase SYRB2. Chembiochem 2006, 7, 748-752.
26. Williams, D.H.; Fleming, I. Spectroscopic Methods in Organic Chemistry, 4th ed.; McGraw-Hill Book Company Limited: London, UK, 1989.
27. Eustaquio, A.S.; Pojer, F.; Noel, J.P.; Moore, B.S. Discovery and characterization of a marine bacterial SAM-dependent chlorinase. Nat. Chem. Biol. 2008, 4, 69-74.
28. Wagner, C.; El Omari, M.; König, G.M. Biohalogenation: Nature's way to synthesize halogenated metabolites. J. Nat. Prod. 2009, 72, 540-553.
29. Ghandi, M.; Bayat, Y.; Teimuri-mofrad, R. A novel method for the synthesis of formyl and hydroxymethyl derivatives of 4H-pyran-4-one. Org. Prep. Proced. Int. 2002, 34, 525-530.
30. Satoh, T.; McKercher, S.R.; Lipton, S.A. Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radical Biol. Med. 2013, 65, 645-657.
31. Wyche, T.P.; Hou, Y.; Braun, D.; Cohen, H.C.; Xiong, M.P.; Bugni, T.S. First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp. J. Org. Chem. 2011, 76, 6542-6547.
32. Fischedick, J.T.; Standiford, M.; Johnson, D.A.; Johnson, J.A. Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway. Bioorg. Med. Chem. 2013, 21, 2618-2622.